ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antiviral Drug Packaging Market Research Report 2025
Published Date: April 2025
|
Report Code: QYRE-Auto-20W14357
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Antiviral Drug Packaging Market Research Report 2023
BUY CHAPTERS

Global Antiviral Drug Packaging Market Research Report 2025

Code: QYRE-Auto-20W14357
Report
April 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Avery Dennison Corporation
E.I. du Pont de Nemours
CCL Industries Inc.
Biocote Limited
Avient
Mondi
Biomaster
BASF AG
Lonza
Takex Labo Co. Ltd
Berry
Lageen Tubes.

Antiviral Drug Packaging Market Size

The global market for Antiviral Drug Packaging was valued at US$ 28320 million in the year 2024 and is projected to reach a revised size of US$ 36460 million by 2031, growing at a CAGR of 3.7% during the forecast period.

Antiviral Drug Packaging Market

Antiviral Drug Packaging Market

Antiviral drug packaging is specially designed for packaging antiviral drugs. Antiviral drugs are a class of medication used specifically for treating viral infections such as influenza, herpes virus infections, viral hepatitis and human immunodeficiency virus.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antiviral Drug Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drug Packaging.
The Antiviral Drug Packaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiviral Drug Packaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Drug Packaging manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Antiviral Drug Packaging Market Report

Report Metric Details
Report Name Antiviral Drug Packaging Market
Accounted market size in year US$ 28320 million
Forecasted market size in 2031 US$ 36460 million
CAGR 3.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Pharmaceuticals
  • Healthcare
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF, Lonza, Takex Labo Co. Ltd, Berry, Lageen Tubes.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Antiviral Drug Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Antiviral Drug Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Antiviral Drug Packaging Market growing?

Ans: The Antiviral Drug Packaging Market witnessing a CAGR of 3.7% during the forecast period 2025-2031.

What is the Antiviral Drug Packaging Market size in 2031?

Ans: The Antiviral Drug Packaging Market size in 2031 will be US$ 36460 million.

Who are the main players in the Antiviral Drug Packaging Market report?

Ans: The main players in the Antiviral Drug Packaging Market are Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF, Lonza, Takex Labo Co. Ltd, Berry, Lageen Tubes.

What are the Application segmentation covered in the Antiviral Drug Packaging Market report?

Ans: The Applications covered in the Antiviral Drug Packaging Market report are Pharmaceuticals, Healthcare

What are the Type segmentation covered in the Antiviral Drug Packaging Market report?

Ans: The Types covered in the Antiviral Drug Packaging Market report are Rigid Plastic, Flexible Blister Foils, Others

Recommended Reports

Drug Packaging

Antiviral & Drug Therapy

Pharmaceutical Solutions

1 Antiviral Drug Packaging Market Overview
1.1 Product Definition
1.2 Antiviral Drug Packaging by Type
1.2.1 Global Antiviral Drug Packaging Market Value Comparison by Type (2024 VS 2031)
1.2.2 Rigid Plastic
1.2.3 Flexible Blister Foils
1.2.4 Others
1.3 Antiviral Drug Packaging by Application
1.3.1 Global Antiviral Drug Packaging Market Value by Application (2024 VS 2031)
1.3.2 Pharmaceuticals
1.3.3 Healthcare
1.4 Global Antiviral Drug Packaging Market Size Estimates and Forecasts
1.4.1 Global Antiviral Drug Packaging Revenue 2020-2031
1.4.2 Global Antiviral Drug Packaging Sales 2020-2031
1.4.3 Global Antiviral Drug Packaging Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Antiviral Drug Packaging Market Competition by Manufacturers
2.1 Global Antiviral Drug Packaging Sales Market Share by Manufacturers (2020-2025)
2.2 Global Antiviral Drug Packaging Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Antiviral Drug Packaging Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Antiviral Drug Packaging, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antiviral Drug Packaging, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antiviral Drug Packaging, Product Type & Application
2.7 Global Key Manufacturers of Antiviral Drug Packaging, Date of Enter into This Industry
2.8 Global Antiviral Drug Packaging Market Competitive Situation and Trends
2.8.1 Global Antiviral Drug Packaging Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Antiviral Drug Packaging Players Market Share by Revenue
2.8.3 Global Antiviral Drug Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Antiviral Drug Packaging Market Scenario by Region
3.1 Global Antiviral Drug Packaging Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Antiviral Drug Packaging Sales by Region: 2020-2031
3.2.1 Global Antiviral Drug Packaging Sales by Region: 2020-2025
3.2.2 Global Antiviral Drug Packaging Sales by Region: 2026-2031
3.3 Global Antiviral Drug Packaging Revenue by Region: 2020-2031
3.3.1 Global Antiviral Drug Packaging Revenue by Region: 2020-2025
3.3.2 Global Antiviral Drug Packaging Revenue by Region: 2026-2031
3.4 North America Antiviral Drug Packaging Market Facts & Figures by Country
3.4.1 North America Antiviral Drug Packaging Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Antiviral Drug Packaging Sales by Country (2020-2031)
3.4.3 North America Antiviral Drug Packaging Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Antiviral Drug Packaging Market Facts & Figures by Country
3.5.1 Europe Antiviral Drug Packaging Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Antiviral Drug Packaging Sales by Country (2020-2031)
3.5.3 Europe Antiviral Drug Packaging Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antiviral Drug Packaging Market Facts & Figures by Region
3.6.1 Asia Pacific Antiviral Drug Packaging Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Antiviral Drug Packaging Sales by Region (2020-2031)
3.6.3 Asia Pacific Antiviral Drug Packaging Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Antiviral Drug Packaging Market Facts & Figures by Country
3.7.1 Latin America Antiviral Drug Packaging Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Antiviral Drug Packaging Sales by Country (2020-2031)
3.7.3 Latin America Antiviral Drug Packaging Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antiviral Drug Packaging Market Facts & Figures by Country
3.8.1 Middle East and Africa Antiviral Drug Packaging Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Antiviral Drug Packaging Sales by Country (2020-2031)
3.8.3 Middle East and Africa Antiviral Drug Packaging Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antiviral Drug Packaging Sales by Type (2020-2031)
4.1.1 Global Antiviral Drug Packaging Sales by Type (2020-2025)
4.1.2 Global Antiviral Drug Packaging Sales by Type (2026-2031)
4.1.3 Global Antiviral Drug Packaging Sales Market Share by Type (2020-2031)
4.2 Global Antiviral Drug Packaging Revenue by Type (2020-2031)
4.2.1 Global Antiviral Drug Packaging Revenue by Type (2020-2025)
4.2.2 Global Antiviral Drug Packaging Revenue by Type (2026-2031)
4.2.3 Global Antiviral Drug Packaging Revenue Market Share by Type (2020-2031)
4.3 Global Antiviral Drug Packaging Price by Type (2020-2031)
5 Segment by Application
5.1 Global Antiviral Drug Packaging Sales by Application (2020-2031)
5.1.1 Global Antiviral Drug Packaging Sales by Application (2020-2025)
5.1.2 Global Antiviral Drug Packaging Sales by Application (2026-2031)
5.1.3 Global Antiviral Drug Packaging Sales Market Share by Application (2020-2031)
5.2 Global Antiviral Drug Packaging Revenue by Application (2020-2031)
5.2.1 Global Antiviral Drug Packaging Revenue by Application (2020-2025)
5.2.2 Global Antiviral Drug Packaging Revenue by Application (2026-2031)
5.2.3 Global Antiviral Drug Packaging Revenue Market Share by Application (2020-2031)
5.3 Global Antiviral Drug Packaging Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Avery Dennison Corporation
6.1.1 Avery Dennison Corporation Company Information
6.1.2 Avery Dennison Corporation Description and Business Overview
6.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio
6.1.5 Avery Dennison Corporation Recent Developments/Updates
6.2 E.I. du Pont de Nemours
6.2.1 E.I. du Pont de Nemours Company Information
6.2.2 E.I. du Pont de Nemours Description and Business Overview
6.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio
6.2.5 E.I. du Pont de Nemours Recent Developments/Updates
6.3 CCL Industries Inc
6.3.1 CCL Industries Inc Company Information
6.3.2 CCL Industries Inc Description and Business Overview
6.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CCL Industries Inc Antiviral Drug Packaging Product Portfolio
6.3.5 CCL Industries Inc Recent Developments/Updates
6.4 BioCote
6.4.1 BioCote Company Information
6.4.2 BioCote Description and Business Overview
6.4.3 BioCote Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BioCote Antiviral Drug Packaging Product Portfolio
6.4.5 BioCote Recent Developments/Updates
6.5 Avient
6.5.1 Avient Company Information
6.5.2 Avient Description and Business Overview
6.5.3 Avient Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Avient Antiviral Drug Packaging Product Portfolio
6.5.5 Avient Recent Developments/Updates
6.6 Mondi
6.6.1 Mondi Company Information
6.6.2 Mondi Description and Business Overview
6.6.3 Mondi Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mondi Antiviral Drug Packaging Product Portfolio
6.6.5 Mondi Recent Developments/Updates
6.7 Biomaster
6.7.1 Biomaster Company Information
6.7.2 Biomaster Description and Business Overview
6.7.3 Biomaster Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biomaster Antiviral Drug Packaging Product Portfolio
6.7.5 Biomaster Recent Developments/Updates
6.8 BASF
6.8.1 BASF Company Information
6.8.2 BASF Description and Business Overview
6.8.3 BASF Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BASF Antiviral Drug Packaging Product Portfolio
6.8.5 BASF Recent Developments/Updates
6.9 Lonza
6.9.1 Lonza Company Information
6.9.2 Lonza Description and Business Overview
6.9.3 Lonza Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Lonza Antiviral Drug Packaging Product Portfolio
6.9.5 Lonza Recent Developments/Updates
6.10 Takex Labo Co. Ltd
6.10.1 Takex Labo Co. Ltd Company Information
6.10.2 Takex Labo Co. Ltd Description and Business Overview
6.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio
6.10.5 Takex Labo Co. Ltd Recent Developments/Updates
6.11 Berry
6.11.1 Berry Company Information
6.11.2 Berry Description and Business Overview
6.11.3 Berry Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Berry Antiviral Drug Packaging Product Portfolio
6.11.5 Berry Recent Developments/Updates
6.12 Lageen Tubes.
6.12.1 Lageen Tubes. Company Information
6.12.2 Lageen Tubes. Description and Business Overview
6.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Lageen Tubes. Antiviral Drug Packaging Product Portfolio
6.12.5 Lageen Tubes. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antiviral Drug Packaging Industry Chain Analysis
7.2 Antiviral Drug Packaging Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antiviral Drug Packaging Production Mode & Process Analysis
7.4 Antiviral Drug Packaging Sales and Marketing
7.4.1 Antiviral Drug Packaging Sales Channels
7.4.2 Antiviral Drug Packaging Distributors
7.5 Antiviral Drug Packaging Customer Analysis
8 Antiviral Drug Packaging Market Dynamics
8.1 Antiviral Drug Packaging Industry Trends
8.2 Antiviral Drug Packaging Market Drivers
8.3 Antiviral Drug Packaging Market Challenges
8.4 Antiviral Drug Packaging Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Avery Dennison Corporation
E.I. du Pont de Nemours
CCL Industries Inc.
Biocote Limited
Avient
Mondi
Biomaster
BASF AG
Lonza
Takex Labo Co. Ltd
Berry
Lageen Tubes.
List of Tables
 Table 1. Global Antiviral Drug Packaging Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Antiviral Drug Packaging Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Antiviral Drug Packaging Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Antiviral Drug Packaging Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Antiviral Drug Packaging Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Antiviral Drug Packaging Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Antiviral Drug Packaging Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Antiviral Drug Packaging Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Antiviral Drug Packaging, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Antiviral Drug Packaging, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Antiviral Drug Packaging, Product Type & Application
 Table 12. Global Key Manufacturers of Antiviral Drug Packaging, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Antiviral Drug Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Packaging as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Antiviral Drug Packaging Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Antiviral Drug Packaging Sales by Region (2020-2025) & (K Units)
 Table 18. Global Antiviral Drug Packaging Sales Market Share by Region (2020-2025)
 Table 19. Global Antiviral Drug Packaging Sales by Region (2026-2031) & (K Units)
 Table 20. Global Antiviral Drug Packaging Sales Market Share by Region (2026-2031)
 Table 21. Global Antiviral Drug Packaging Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Antiviral Drug Packaging Revenue Market Share by Region (2020-2025)
 Table 23. Global Antiviral Drug Packaging Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Antiviral Drug Packaging Revenue Market Share by Region (2026-2031)
 Table 25. North America Antiviral Drug Packaging Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Antiviral Drug Packaging Sales by Country (2020-2025) & (K Units)
 Table 27. North America Antiviral Drug Packaging Sales by Country (2026-2031) & (K Units)
 Table 28. North America Antiviral Drug Packaging Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Antiviral Drug Packaging Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Antiviral Drug Packaging Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Antiviral Drug Packaging Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Antiviral Drug Packaging Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Antiviral Drug Packaging Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Antiviral Drug Packaging Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Antiviral Drug Packaging Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Antiviral Drug Packaging Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Antiviral Drug Packaging Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Antiviral Drug Packaging Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Antiviral Drug Packaging Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Antiviral Drug Packaging Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Antiviral Drug Packaging Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Antiviral Drug Packaging Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Antiviral Drug Packaging Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Antiviral Drug Packaging Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Antiviral Drug Packaging Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Antiviral Drug Packaging Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Antiviral Drug Packaging Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Antiviral Drug Packaging Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Antiviral Drug Packaging Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Antiviral Drug Packaging Sales (K Units) by Type (2020-2025)
 Table 51. Global Antiviral Drug Packaging Sales (K Units) by Type (2026-2031)
 Table 52. Global Antiviral Drug Packaging Sales Market Share by Type (2020-2025)
 Table 53. Global Antiviral Drug Packaging Sales Market Share by Type (2026-2031)
 Table 54. Global Antiviral Drug Packaging Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Antiviral Drug Packaging Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Antiviral Drug Packaging Revenue Market Share by Type (2020-2025)
 Table 57. Global Antiviral Drug Packaging Revenue Market Share by Type (2026-2031)
 Table 58. Global Antiviral Drug Packaging Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Antiviral Drug Packaging Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Antiviral Drug Packaging Sales (K Units) by Application (2020-2025)
 Table 61. Global Antiviral Drug Packaging Sales (K Units) by Application (2026-2031)
 Table 62. Global Antiviral Drug Packaging Sales Market Share by Application (2020-2025)
 Table 63. Global Antiviral Drug Packaging Sales Market Share by Application (2026-2031)
 Table 64. Global Antiviral Drug Packaging Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Antiviral Drug Packaging Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Antiviral Drug Packaging Revenue Market Share by Application (2020-2025)
 Table 67. Global Antiviral Drug Packaging Revenue Market Share by Application (2026-2031)
 Table 68. Global Antiviral Drug Packaging Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Antiviral Drug Packaging Price (US$/Unit) by Application (2026-2031)
 Table 70. Avery Dennison Corporation Company Information
 Table 71. Avery Dennison Corporation Description and Business Overview
 Table 72. Avery Dennison Corporation Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Avery Dennison Corporation Antiviral Drug Packaging Product
 Table 74. Avery Dennison Corporation Recent Developments/Updates
 Table 75. E.I. du Pont de Nemours Company Information
 Table 76. E.I. du Pont de Nemours Description and Business Overview
 Table 77. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. E.I. du Pont de Nemours Antiviral Drug Packaging Product
 Table 79. E.I. du Pont de Nemours Recent Developments/Updates
 Table 80. CCL Industries Inc Company Information
 Table 81. CCL Industries Inc Description and Business Overview
 Table 82. CCL Industries Inc Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. CCL Industries Inc Antiviral Drug Packaging Product
 Table 84. CCL Industries Inc Recent Developments/Updates
 Table 85. BioCote Company Information
 Table 86. BioCote Description and Business Overview
 Table 87. BioCote Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. BioCote Antiviral Drug Packaging Product
 Table 89. BioCote Recent Developments/Updates
 Table 90. Avient Company Information
 Table 91. Avient Description and Business Overview
 Table 92. Avient Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Avient Antiviral Drug Packaging Product
 Table 94. Avient Recent Developments/Updates
 Table 95. Mondi Company Information
 Table 96. Mondi Description and Business Overview
 Table 97. Mondi Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Mondi Antiviral Drug Packaging Product
 Table 99. Mondi Recent Developments/Updates
 Table 100. Biomaster Company Information
 Table 101. Biomaster Description and Business Overview
 Table 102. Biomaster Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Biomaster Antiviral Drug Packaging Product
 Table 104. Biomaster Recent Developments/Updates
 Table 105. BASF Company Information
 Table 106. BASF Description and Business Overview
 Table 107. BASF Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. BASF Antiviral Drug Packaging Product
 Table 109. BASF Recent Developments/Updates
 Table 110. Lonza Company Information
 Table 111. Lonza Description and Business Overview
 Table 112. Lonza Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Lonza Antiviral Drug Packaging Product
 Table 114. Lonza Recent Developments/Updates
 Table 115. Takex Labo Co. Ltd Company Information
 Table 116. Takex Labo Co. Ltd Description and Business Overview
 Table 117. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Takex Labo Co. Ltd Antiviral Drug Packaging Product
 Table 119. Takex Labo Co. Ltd Recent Developments/Updates
 Table 120. Berry Company Information
 Table 121. Berry Description and Business Overview
 Table 122. Berry Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Berry Antiviral Drug Packaging Product
 Table 124. Berry Recent Developments/Updates
 Table 125. Lageen Tubes. Company Information
 Table 126. Lageen Tubes. Description and Business Overview
 Table 127. Lageen Tubes. Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Lageen Tubes. Antiviral Drug Packaging Product
 Table 129. Lageen Tubes. Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Antiviral Drug Packaging Distributors List
 Table 133. Antiviral Drug Packaging Customers List
 Table 134. Antiviral Drug Packaging Market Trends
 Table 135. Antiviral Drug Packaging Market Drivers
 Table 136. Antiviral Drug Packaging Market Challenges
 Table 137. Antiviral Drug Packaging Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Antiviral Drug Packaging
 Figure 2. Global Antiviral Drug Packaging Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Antiviral Drug Packaging Market Share by Type: 2024 & 2031
 Figure 4. Rigid Plastic Product Picture
 Figure 5. Flexible Blister Foils Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Antiviral Drug Packaging Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Antiviral Drug Packaging Market Share by Application: 2024 & 2031
 Figure 9. Pharmaceuticals
 Figure 10. Healthcare
 Figure 11. Global Antiviral Drug Packaging Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Antiviral Drug Packaging Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Antiviral Drug Packaging Sales (2020-2031) & (K Units)
 Figure 14. Global Antiviral Drug Packaging Average Price (US$/Unit) & (2020-2031)
 Figure 15. Antiviral Drug Packaging Report Years Considered
 Figure 16. Antiviral Drug Packaging Sales Share by Manufacturers in 2024
 Figure 17. Global Antiviral Drug Packaging Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Antiviral Drug Packaging Players: Market Share by Revenue in Antiviral Drug Packaging in 2024
 Figure 19. Antiviral Drug Packaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Antiviral Drug Packaging Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Antiviral Drug Packaging Sales Market Share by Country (2020-2031)
 Figure 22. North America Antiviral Drug Packaging Revenue Market Share by Country (2020-2031)
 Figure 23. United States Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Antiviral Drug Packaging Sales Market Share by Country (2020-2031)
 Figure 26. Europe Antiviral Drug Packaging Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Antiviral Drug Packaging Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Antiviral Drug Packaging Revenue Market Share by Region (2020-2031)
 Figure 34. China Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Antiviral Drug Packaging Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Antiviral Drug Packaging Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Antiviral Drug Packaging Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Antiviral Drug Packaging Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Antiviral Drug Packaging Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Antiviral Drug Packaging by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Antiviral Drug Packaging by Type (2020-2031)
 Figure 53. Global Antiviral Drug Packaging Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Antiviral Drug Packaging by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Antiviral Drug Packaging by Application (2020-2031)
 Figure 56. Global Antiviral Drug Packaging Price (US$/Unit) by Application (2020-2031)
 Figure 57. Antiviral Drug Packaging Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Antivirals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Sterile and Antiviral Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza Flu Antiviral Drugs Market Insights Forecast to 2030
Global Antiviral Polymers for Packaging Market Research Report 2024
Global Ophthalmic Antivirals Market Research Report 2025
Global Antiviral and Antibacterial Coating Market Research Report 2024
Drugs Glass Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Therapy Viral Packaging Service Market Research Report 2024
Global Infectious Substance Packaging Market Research Report 2024
Global Research Grade Viral Vector Packaging Service Market Research Report 2025
Global Antimicrobial antiviral Coating Market Research Report 2024
Antiviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antiviral Antimicrobial Coatings Market Research Report 2024
Viral Vector Packaging Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Packaging for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antiviral Drugs for Influenza Market Research Report 2025
Global Antibacterial And Antiviral Paint Market Research Report 2024
Hepatic Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Temperature Controlled Packaging Solutions for Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmology Packaging Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions